You are here

MTI Biotech Incorporated

Company Information
Address
2711 S Loop Dr Ste 4400
Ames, IA 50010-8656
United States


http://www.mtibiotech.com

Information

UEI: N5NDNJL8QGA1

# of Employees: 12


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. 2-HOBA for Treatment of Pulmonary Hypertension

    Amount: $1,173,060.00

    PROJECT SUMMARY Although the ubiquity of metabolic problems in pulmonary hypertension (PH) has been known for more than a decade, a wealth of new details on the nature of this problem presents the opp ...

    STTRPhase II2023Department of Health and Human Services National Institutes of Health
  2. Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis

    Amount: $400,000.00

    SUMMARY: Many cancers are recognized to have an inflammatory etiology. Gastric cancer, the third leading cause of cancer deaths worldwide, is the prototype- it is caused by infection with the bacteria ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health
  3. 2-HOBA for Treatment of Pulmonary Hypertension

    Amount: $256,580.00

    PROJECT SUMMARY Although the ubiquity of metabolic problems in pulmonary hypertension (PH) has been known for more than a decade, a wealth of new details on the nature of this problem presents the opp ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health
  4. Hydroxybenzylamine for the prevention of Alzheimer s disease Initial evaluation in humans

    Amount: $1,506,752.00

    Approximately million Americans are affected by Alzheimer s disease AD and up to million will be affected by At present there is no preventive or curative treatment for AD or in age r ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  5. Gamma-ketoaldehyde scavengers for alcoholic liver disease

    Amount: $151,587.00

    DESCRIPTION (provided by applicant): Chronic alcohol overconsumption is the third largest risk factor for disease burden worldwide and is a frequent comorbidity of liver disease and cancer. While abst ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  6. Nutritional Intervention for Age Related Muscular Function and Strength Losses

    Amount: $847,743.00

    DESCRIPTION provided by applicant Sarcopenia defined as age related loss of muscle mass and muscle function and strength is very prevalent among the elderly Sarcopenia is one of the largest publ ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  7. SBIR Phase I: Metabolic Engineering of Moritella marina MP-1 for DHA Production

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project aims to evaluate the use of a marine organism for production of the polyunsaturated fatty acid (PUFA), docosahexaenoic acid (DHA). DHA is ...

    SBIRPhase I2013National Science Foundation
  8. Nutritional Intervention for Age-Related Muscular Function and Strength Losses

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Sarcopenia, defined as age related loss of muscle mass and muscle function and strength, is very prevalent among the elderly. Sarcopenia is one of the largest publ ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  9. Development of Solanum glaucophyllum as a Source of Vitamin D for Laying Hens

    Amount: $80,000.00

    Egg breakage and cracking is a major economical problem for the US poultry industry which can affect up to 10% of the eggs produced. The resulting approximately 500 million dollars in lost revenue to ...

    SBIRPhase I2005Department of Agriculture
  10. Nutritional Intervention for Older Adult Muscle Loss

    Amount: $743,098.00

    DESCRIPTION (provided by applicant): Age-related muscle loss is a major public health issue affecting over 30 million Americans, with no viable treatments available to stem about an 8% loss in muscle ...

    SBIRPhase II2004Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government